Aligos Therapeutics, Inc. short interest in 2025
In 2025, Aligos Therapeutics, Inc.'s disclosed short interest ran from 18.52% of shares outstanding on 15 Jan 2025 to 1.53% on 31 Dec 2025, a change of -16.99 percentage points. The year's high was 20.13% on 28 Feb 2025 and its low 1.44% on 28 Nov 2025, averaging 6.05% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.38 days on 30 Apr 2025. Full history: Aligos Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 18.52% (15 Jan 2025)
- End of year
- 1.53% (31 Dec 2025)
- Change
- -16.99 pp
- High
- 20.13% (28 Feb 2025)
- Low
- 1.44% (28 Nov 2025)
- Average
- 6.05%
- Highest days to cover
- 8.38 (30 Apr 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 18.52% | 1.56 | |
| 31 Jan 2025 | 16.06% | 2.29 | |
| 14 Feb 2025 | 19.87% | 2.59 | |
| 28 Feb 2025 | 20.13% | 3.53 | |
| 14 Mar 2025 | 6.50% | 4.25 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 6.73% | 7.20 | |
| 15 Apr 2025 | 6.80% | 3.39 | |
| 30 Apr 2025 | 6.83% | 8.38 | |
| 15 May 2025 | 5.23% | 3.24 | 10-Q filed, results (8-K) |
| 30 May 2025 | 4.52% | 4.67 | |
| 13 Jun 2025 | 4.43% | 3.34 | |
| 30 Jun 2025 | 4.36% | 5.48 | |
| 15 Jul 2025 | 3.20% | 4.30 | |
| 31 Jul 2025 | 2.94% | 5.00 | |
| 15 Aug 2025 | 2.46% | 5.23 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 2.54% | 3.15 | |
| 15 Sep 2025 | 2.38% | 5.79 | |
| 30 Sep 2025 | 2.22% | 3.55 | |
| 15 Oct 2025 | 1.91% | 2.42 | |
| 31 Oct 2025 | 1.45% | 2.44 | |
| 14 Nov 2025 | 1.49% | 2.91 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 1.44% | 2.77 | |
| 15 Dec 2025 | 1.64% | 2.91 | |
| 31 Dec 2025 | 1.53% | 4.70 |
See also: Aligos Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.